| Patents for C07D 217 - Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems (11,865) |
|---|
| 09/04/2002 | CN1090176C Purification of nitrile |
| 09/03/2002 | US6444672 Heterocyclic derivatives and their use as antithrombotic agents |
| 09/03/2002 | CA2234051C Novel isoquinoline derivatives |
| 08/29/2002 | WO2001087845A3 N-containing heterocyclic compounds and their use as 5-ht antagonists |
| 08/28/2002 | EP1233947A1 Preparation of 3-substituted-4-arylquinolin-2-one derivatives |
| 08/28/2002 | EP1233743A1 Compositions for dyeing keratinous fibres containing 3-amino pyrazolo- 1,5-a]-pyridines, dyeing method, novel 3-amino pyrazolo- 1,5-a]-pyridines |
| 08/28/2002 | CN1366518A Biphenyl butyric acid derivative as matrix metalloproteinase inhibitor |
| 08/27/2002 | US6441193 Intermediates such as 1-(2-(4-(6-methoxy-3,4-dihydronaphtha-len-1-yl)phenoxy)ethyl)pyrrolidine and compounds such as cis-6-phenyl-5-(4-(2-pyrrolidin-1-ylethoxy)phenyl)-5,6,7,8 -tetrahydronaphthalen-2-ol, hydrobromide salt |
| 08/27/2002 | US6441175 Useful in treating various neuropsychological disorders including, schizophrenia, dementia, depression, anxiety, parkinson-like motor disorders and motion disorders |
| 08/27/2002 | US6440969 Certain isoquinolinamine and phthalazinamine derivatives: corticotropin-releasing factor receptor CRF1 specific ligands |
| 08/27/2002 | CA2224738C Use of ritonavir (abt-538) for improving the pharmacokinetics of drugs metabolized by cytochrome p450 in a method of treating aids |
| 08/22/2002 | WO2002064576A1 Heteroaryl alkyl piperazine derivatives as fatty acid oxidation inhibitors |
| 08/22/2002 | US20020115863 Hydroxamate derivatives that inhibit peptidyl deformylase (PDF), antimicrobials and antibiotics |
| 08/22/2002 | CA2426535A1 Heteroaryl alkyl piperazine derivatives as fatty acid oxidation inhibitors |
| 08/20/2002 | US6437134 Silylating the corresponding carbamate compound; alkylation |
| 08/20/2002 | US6437128 Cribrostatins 3-5 |
| 08/20/2002 | US6436923 Compounds and methods for modulation of estrogen receptors |
| 08/20/2002 | US6436152 Substituted 2-aminoalky-1,4-diaminobenzene compounds and oxidation dye precursor compositions containing same |
| 08/15/2002 | WO2002062764A1 Fused heterocyclic compounds |
| 08/15/2002 | WO2002062763A2 Inhibition of raf kinase using quinolyl isoquinolyl or pyridyl ureas |
| 08/15/2002 | WO2002042265A3 Cyanoguanidine prodrugs |
| 08/15/2002 | US20020111364 ABCA-1 elevating compounds |
| 08/15/2002 | CA2437492A1 Fused heterocyclic compounds |
| 08/14/2002 | EP0722439B1 Hiv protease inhibitors |
| 08/13/2002 | US6433177 Reacting n-carboxyanhydride and butylamine |
| 08/13/2002 | US6432962 Antiinflammatory agents |
| 08/13/2002 | US6432955 Heterocyclic derivatives and their use as antithrombotic agents |
| 08/13/2002 | US6432933 Malaria therapy; alzheimer's disorders |
| 08/13/2002 | CA2063938C Novel azadecalin amides and thioamides as inhibitors of cholesterol biosynthesis |
| 08/08/2002 | US20020107241 N-heterocyclic derivatives useful for treating or preventing neuronal damage associated with neurological disease |
| 08/07/2002 | EP1228069A2 Bicyclic and tricyclic heteroaromatic compounds |
| 08/07/2002 | EP1228043A1 Isoquinoline and quinazoline deivatives having a combined 5ht1a, 5ht1b and 5ht1d receptor activity |
| 08/07/2002 | EP1228024A1 Novel hydronaphtalene compounds, prepared by a rhodium catalyzed ring opening reaction in the presence of phosphine ligand |
| 08/07/2002 | EP0801649B1 Hydroxylamine derivatives useful for enhancing the molecular chaperon production and the preparation thereof |
| 08/07/2002 | CN1088709C Amine compound and its acid addition salt |
| 08/06/2002 | US6429212 Aminopeptidase n inhibitor used to treat cancer, tumors, and retinopathy; few side effects; angiogenesis inhibitor |
| 08/06/2002 | US6429207 Metabotropic glutamate receptor antagonists and their use for treating central nervous system diseases |
| 08/06/2002 | CA2231812C Cyclic nitrones and pharmaceutical compositions containing them |
| 08/01/2002 | WO2002059117A1 Piperazine- and piperidine-derivatives as melanocortin receptor agonists |
| 08/01/2002 | WO2002059108A1 Melanocortin receptor agonists |
| 08/01/2002 | WO2002059107A1 Substituted piperidines/piperazines as melanocortin receptor agonists |
| 08/01/2002 | WO2002059095A1 Melanocortin receptor agonists |
| 08/01/2002 | WO2002059074A1 Benzylamine analogue |
| 08/01/2002 | US20020103239 Such as N-hydroxy-2-(((4-phenoxyphenyl)-sulfonyl)methyl) benzamide which inhibits matrix metalloprotease activity |
| 08/01/2002 | US20020103203 For treating cancer and other disease states associated with unwanted angiogenesis and/or cellular proliferation such as diabetic retinopathy, neovascular glaucoma, rheumatoid arthritis, psoriasis |
| 08/01/2002 | CA2435883A1 Benzylamine analogue |
| 08/01/2002 | CA2433025A1 Substituted piperidines/piperazines as melanocortin receptor agonists |
| 08/01/2002 | CA2432988A1 Melanocortin receptor agonists |
| 08/01/2002 | CA2432985A1 Piperazine- and piperidine-derivatives as melanocortin receptor agonists |
| 08/01/2002 | CA2431996A1 Melanocortin receptor agonists |
| 07/31/2002 | EP1226137A1 Phenyl- and pyridyl-tetrahydro-pyridines having tnf inhibiting activity |
| 07/31/2002 | EP1225886A2 Method of inhibiting amyloid protein aggregation and imaging amyloid deposits |
| 07/31/2002 | EP0719267B1 Second messenger cell signaling inhibitors |
| 07/31/2002 | CN1361768A Metabotropic glutamate receptor antagonists and their use for treating central nervous system diseases |
| 07/30/2002 | US6426415 Polyadenosine 5'-diphospho-ribose polymerase (parp) enzyme inhibitors, alkoxy substituted n-heterocycle derivatives |
| 07/30/2002 | CA2056619C Method of inactivation of viral and bacterial blood contaminants |
| 07/25/2002 | WO2002057256A1 Piperazinylcarbonylquinolines and -isoquinolines |
| 07/25/2002 | WO2002057218A1 Alanine 2,6-dialkoxyphenyl ester derivatives as hypnotics |
| 07/24/2002 | EP1224177A1 Process for preparing oxazolines from tetrahydrofurans |
| 07/24/2002 | EP1224165A1 Novel compounds |
| 07/24/2002 | EP0804431B1 GLYCOPROTEIN IIb/IIIa ANTAGONISTS |
| 07/23/2002 | US6423690 Antibacterial agents |
| 07/18/2002 | US20020095056 Hydrogenation of an imine in the presence of a base and, a ruthenium complex of a chiral diphosphine and diamine catalyst |
| 07/18/2002 | US20020095055 Reacting a tertiary or secondary amine with hydrogen peroxide in presence of a recyclable heterogeneous layered double hydroxide exchanged with one of the anions of transition metal oxides as a catalyst in a solvent |
| 07/18/2002 | DE10102053A1 Piperazinylcarbonyl-quinoline and piperazinylcarbonyl-isoquinoline derivatives useful for treatment of e.g. schizophrenia, psychoses, depression, Parkinson's disease and Alzheimer's disease |
| 07/17/2002 | EP1222924A1 Anticancer agents |
| 07/17/2002 | EP1222187A2 Heterocyclic compounds useful as inhibitors of tyrosine kinases |
| 07/17/2002 | EP0801568B1 Compounds for inhibition of ceramide-mediated signal transduction |
| 07/16/2002 | US6420556 Multistage reaction for hypotensive agents or cardiotonic agents |
| 07/16/2002 | US6420438 1-amino-7-isoquinoline derivatives as serine protease inhibitors |
| 07/11/2002 | WO2002053545A1 Process for preparation of aromatic halides from aromatic amines |
| 07/11/2002 | WO2002053543A1 Pyridone derivative having affinity for cannabinoid 2-type receptor |
| 07/11/2002 | WO2002008221A3 Capsaicin receptor ligands |
| 07/11/2002 | US20020091264 Compounds containing dibenzo(A,D)cycloheptene or dibenz(B,F)oxepine derivatives are useful for treating osteoporosis, cardiovascular diosrders, cancer and inflammation |
| 07/11/2002 | US20020091121 Use of estrogen antagonists and estrogen agonists in inhibiting pathological conditions |
| 07/11/2002 | US20020091116 Show selectivity for factor Xa versus other proteases of coagulation or the fibrinolytic cascades |
| 07/11/2002 | US20020091089 (Substituted)acyl dipeptidyl inhibitors of the ICE/ced-3 family of cysteine proteases |
| 07/10/2002 | CN1358172A Indanyl-substituted benzole carbonamide, method for the production of the same, use thereof as medicament and pharmaceutical preparations containing the same |
| 07/10/2002 | CN1358062A 巨噬细胞清除剂受体拮抗剂 Macrophage scavenger receptor antagonists |
| 07/10/2002 | CN1087294C Novel compounds |
| 07/09/2002 | US6417362 Piperazine derivatives; arteriosclerosis, pancreatitis, and cardiovascular disorder treatment; side effect reduction |
| 07/09/2002 | US6417195 Isoquinoline derivatives and isoquinoline combinatorial libraries |
| 07/04/2002 | WO2002051842A1 Tetrahydropyridine derivatives, their preparation and their use as cell proliferation inhibitors |
| 07/04/2002 | WO2002051812A1 Method for extracting bisbenzylisoquinolines |
| 07/04/2002 | US20020086999 Certain quinoline derivatives |
| 07/04/2002 | CA2431471A1 Tetrahydropyridine derivatives, their preparation and their use as cell proliferation inhibitors |
| 07/03/2002 | EP1219294A1 Melanin concentrating hormone antagonists |
| 07/03/2002 | EP0563345B1 Novel 4-arylpiperazines and 4-arylpiperidines |
| 07/02/2002 | US6414154 Tetraisoquinoline derivatives as modulators of dopamine D3 receptors |
| 07/02/2002 | CA2062877C Succinic acid compounds |
| 06/27/2002 | WO2002050081A2 Antimicrobial agents |
| 06/27/2002 | WO2002049993A2 High affinity small molecule c5a receptor modulators |
| 06/27/2002 | US20020082257 Elevates ATP binding cassette transporter 1 expression thereby increasing efflux of cholesterol from cells by active transfer into high density lipoproteins |
| 06/27/2002 | US20020082254 Inhibitors of hormone-sensitive lipase; decreasing plasma free fatty acid levels found with diabetes type 2, insulin resistance, impaired glucose tolerance, hyperglycemia, dyslipidemia, or lipoprotein metabolism abnormalities |
| 06/26/2002 | EP1216980A1 Carboxylic acid derivatives and drugs containing the same |
| 06/26/2002 | EP1216232A1 Heterocyclic compounds and methods for modulating cxcr3 function |
| 06/26/2002 | EP1216231A2 INHIBITORS OF FACTOR Xa |
| 06/26/2002 | EP1216228A2 BENZAMIDES AND RELATED INHIBITORS OF FACTOR Xa |
| 06/25/2002 | US6410561 Analgesics |
| 06/25/2002 | US6410480 Plant safening agents and growth regulators for controlling weeds and grasses; post/preemergence herbicides |